News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Integrated analysis supports long-term efficacy of ritlecitinib for alopecia areata
28 Jul 2023
byAudrey Abella
An integrated analysis of the pivotal phase IIb/III ALLEGRO and phase III ALLEGRO-LT studies demonstrated the long-term efficacy of the oral JAK3/TEC family kinase inhibitor ritlecitinib for alopecia areata (AA).
28 Jul 2023

Niraparib maintenance confers prolonged survival in advanced ovarian cancer
27 Jul 2023
Maintenance therapy with niraparib appears to increase progression-free survival (PFS) in patients with advanced ovarian cancer, irrespective of postoperative residual disease or biomarker status, according to data from the phase III PRIME study.
27 Jul 2023






